✦ LIBER ✦

Cyclophosphamide in the management of Ewing's sarcoma

✍ Scribed by M. L. Samuels; C. D. Howe

Publisher: John Wiley and Sons
Year: 1967
Tongue: English
Weight: 522 KB
Volume: 20
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(196706)20:6<961::aid-cncr2820200605>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management and results of localized Ewin

Management and results of localized Ewing's sarcoma

✍ Rafael C. Chan; Wataru W. Sutow; Robert D. Lindberg; Melvin L. Samuels; John A. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

Role of computed tomography scanning in

Role of computed tomography scanning in the management of Ewing's sarcoma

✍ Williams, Michael P. ;Husband, Janet E. ;McElwain, T. J. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

Management of extraosseous Ewing sarcoma

Management of extraosseous Ewing sarcoma of the infratemporal fossa

✍ Lee, R. Jeffrey; Smith, Sharon H.; Hicks, Wesley L.; Iqbal, Vaseem; Green, Danie 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

This previously healthy 13-year-old female presented with a 2-month history of a slow-growing mass in the left temporal region. Review of systems was unremarkable. CT scan and MRI scan were obtained at an outside institution for further evaluation of the mass. ## Vaseem Iqbal, MD (Diagnostic Radiol

Efficacy of cyclophosphamide in the mana

Efficacy of cyclophosphamide in the management of reticulum cell sarcoma

✍ George A. Hyman; Peter A. Cassileth 📂 Article 📅 1966 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

CNS involvement in Ewing's sarcoma

✍ Yashbir Mehta; Frank R. Hendrickson 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

Adjuvant chemotherapy in Ewing's sarcoma

✍ Dr. S. H. Advani; D. N. Rao; K. A. Dinshaw; C. N. Nair; R. Gopal; J. J. Vyas; P. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB

Adjuvant chemotherapy using vincristine, cyclophosphamide, and adriamycin was used in 28 patients with localized Ewing's sarcoma. Life-table analysis revealed 55% disease-free survival at 3 years. In contrast, our historical control showed less than 10% long-term survival. Adjuvant chemotherapy appe